Oxford Metrics H1 loss amid strategic shifts & acquisitions. Full-year outlook backed; strong cash position fuels growth and shareholder returns.
This article covers information on Oxford Metrics PLC.
LON:OMGOxford Metrics (LSE: OMG) delivered interim results for H1 FY25 (ended 31 March 2025) that, on the surface, show a step back. Revenue dipped 14% year-on-year to £20.1m, swinging from a £3.7m statutory profit before tax in H1 FY24 to a £0.7m loss. Adjusted EBIT also landed in the red at £0.4m, compared to a £3.0m profit last year. The culprit? An exceptionally strong H1 FY24, fuelled by delivering a record order book built up during pandemic-era supply chain snarls. CEO Imogen O’Connor was clear: this wasn’t a trend expected to continue, and the dip was in line with management expectations. Crucially, the full-year outlook remains unchanged.
Despite the loss, the balance sheet remains a fortress. Net cash stands at £39.9m (down from £54.8m, but still substantial), bolstered by strong operating cash flow of £2.8m. This war chest funded the acquisitions (£5.5m for Sempre, £0.8m for Amber Optix), a progressive dividend hike (£4.2m paid, up from £3.6m), and a share buyback (£3.6m spent so far). Tellingly, the Board just extended the buyback by another £4m, taking the total programme to £10m – a clear signal of confidence in intrinsic value.
Revenue here fell 32% to £14.8m, mirroring the Group trend against that tough prior year comparator. Margins held up well. While the core marker-based business saw solid progress (new contracts/upgrades globally, e.g., Brazil rehab hospitals, major entertainment producers in US/Japan/Korea, Sandbox VR expansion), the real story is Vicon Markerless.
Regional demand is mixed: improving in South America, APAC, and Europe for Entertainment/Life Sciences, but hampered by the US funding environment.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
81 viewsLikes
No ratings yet
This is where the growth engine is firing. Revenue skyrocketed 194% to £5.3m, primarily fuelled by the Sempre acquisition (£3.6m contribution). Organic growth was slightly down (-3%) due to contract timing delays (since delivered). Adjusted EBIT rose to £0.7m (H1 FY24: £0.5m).
Visibility for H2 is good, with a building order book extending beyond FY25.
That £39.9m net cash position is the bedrock of Oxford Metrics’ strategy. It enabled the acquisitions, funds ongoing R&D (including Markerless), and supports generous shareholder returns:
The Board reaffirms FY25 Adjusted EBIT expectations, despite the H1 loss and acknowledged headwinds (US funding, macro uncertainty). Why the confidence?
The journey involves navigating some near-term chop, particularly in the US academic sector. However, Oxford Metrics is actively investing in its future (Markerless, Smart Manufacturing integration & acquisitions) while rewarding shareholders. The extension of the buyback programme speaks volumes about the Board’s view of the company’s value proposition. One to watch closely as the strategic shifts and new product cycles gain traction in H2 and beyond. Keep your eyes peeled for that new three-year strategy promised with the full-year results.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.